Identifying genetic causes of heart issues in epilepsy patients
Official title: Genetic Markers of Cardiovascular Diseases and the Potential Role in Sudden Unexpected Death in Epilepsy.
Run by Mayo Clinic · NCT02824822 · Data updated 2026-11-12
This study is trying to find out if certain genetic factors can help explain why some young adults with epilepsy are at risk for sudden death.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 50 Years |
| Sex | All |
| Enrollment | 600 (estimated) |
| Sponsor | Mayo Clinic Academic / other |
| Locations | 1 site (Rochester, Minnesota) |
| Status | Recruiting |
| Started | May 2016 |
| Main results expected | December 2031 |
| Study ends | December 2031 |
| Registry record updated | November 3, 2026 |
| Trial ID | NCT02824822 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 to 50 with epilepsy or related conditions who are at high risk for sudden unexpected death.
✕Probably not a fit
Patients with seizures due to ischemic events or those with a history of cranial surgery or brain tumors may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to explore the genetic factors that may contribute to sudden unexpected death in patients with epilepsy. It focuses on individuals aged 18 to 50 who are at high risk for sudden death due to their epilepsy or related conditions. Participants will be assessed using a risk scoring tool and may include blood relatives of patients with a history of epilepsy or cardiac issues. Genetic testing will be conducted using blood samples or buccal cells to identify potential underlying cardiovascular disorders.
Why it matters
Potential benefit: If successful, this study could lead to better understanding and prevention of sudden unexpected death in epilepsy patients.
How similar studies have gone: Other studies have shown promise in identifying genetic markers related to cardiovascular issues in epilepsy, suggesting this approach may yield valuable insights.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults ages 18 - 50 with a diagnosis of epilepsy or seizures, or syncope or drowning or cardiac arrest or sudden death or an abnormal ECG suggestive of an arrhythmia * Blood-relatives (Aged 18+) of a patient with a history of epilepsy, seizure, cardiac arrest, sudden death, drowning, syncope or arrhythmia Exclusion Criteria: * Those who are unable to provide written consent. * Prisoners (vulnerable population) * Seizures secondary to ischemic events * Traumatic brain injury resulting in seizures * History of cranial surgery * History of brain tumor
Where it's running
-
Mayo Clinic
Rochester, Minnesota, United States Recruiting
Study contacts
- Principal investigator: Virend K. Somers, MD PhD — Mayo Clinic
- Study coordinator: Somers CPL Lab
- Email: CPL@mayo.edu
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Levetiracetam to prevent seizures in adults with Down syndrome and Alzheimer's disease
This trial will test whether the anti-seizure medicine levetiracetam can prevent tonic-clonic seizures and slow cognitive decline in adults over 40 who have Down syndrome and symptomatic Alzheimer's disease.
-
Wearable device for detecting seizures
This study tests a new wearable device for detecting seizures in people with epilepsy to see if it works well and can help them feel more comfortable in their daily lives.
-
Investigating factors that lead to epilepsy after a stroke
This study is trying to find out what factors might cause epilepsy in people who have had a stroke by comparing them to healthy individuals.
-
Effects of scopolamine on brain activity related to memory in epilepsy patients
This study is testing if the drug scopolamine can change how well people with epilepsy remember things by looking at their brain activity while they do memory tasks.
-
Creation of a database linking EEG recordings with clinical information for epilepsy patients
This study is creating a database that links brain wave recordings and medical information from epilepsy patients to see if it can help improve treatment and predict seizures better.
-
Analyzing brain imaging biomarkers in patients with cerebral cavernous malformation-related epilepsy
This study is trying to see if brain scans can help find signs of iron buildup in people with cerebral cavernous malformation and epilepsy, which could improve how we manage their condition.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.